Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00221897 · ClinicalTrials.gov registry record

Diagnostic Innovations in Glaucoma Study

A clinical trial of Myopia and Primary Open Angle Glaucoma, sponsored by University of California, San Diego.

Recruiting
Registry status
3,000
Enrollment target
1
Study location

NCT00221897: Recruiting study of Myopia and Primary Open Angle Glaucoma, sponsored by University of California, San Diego.

NCT00221897 is a study of Myopia and Primary Open Angle Glaucoma that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 3,000 participants, above the 235-participant average among 90 other Myopia trials with a reported enrollment target (1177% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00221897, a study of Myopia and Primary Open Angle Glaucoma, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
3,000 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of our research study is to evaluate changes in visual function and optic nerve topography (the structure of the back of the eye) in patients with glaucoma (increased susceptibility to pressure inside the eye that can cause loss of vision) or those with an increased risk of developing the disease. The purpose of this study is to determine the best methods for detecting the presence or progression (worsening over time) of glaucoma in patients with and without myopia and its effects on daily and visual function and quality of life. With several sources of NIH and foundation funding over the last twenty years we have designed a robust research protocol to address the most challenging aspects of glaucoma management. The most recent focus of this research is 1) to improve our ability to detect open angle glaucoma in individuals with myopia and in individuals of European and African descent, 2) to determine whether monitoring of the retinal vasculature with new optical imaging instruments can improve glaucoma management and elucidate the pathophysiology of the disease, and 3) to differentiate between age-related changes and glaucomatous progression. The grants supporting this project include 3 NIH funded studies, 1) the University of California, San Diego UCSD -based "Diagnostic Innovations in Glaucoma Study" (DIGS funded since 1995): 2) the "African Descent and Glaucoma Evaluation Study" (ADAGES funded since 2002), 3) the Brightfocus Foundation National Glaucoma Research Program and 4) the UCSD-based "Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography" (funded since 2018). The ADAGES is a multi-center study with data collection also conducted at 2 other academic sites, the University of Alabama at Birmingham, and Columbia University. Enrolled healthy participants, glaucoma suspects and glaucoma patients are generally asked to return for two or more visits a year for several years. We then analyze whether the glaucoma

Study Locations (1)

California

  • UCSD, Hamilton Glaucoma Center - La Jolla

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 1995-04
Est. Completion 2030-07
University of California, San Diego

775 total trials

What NCT00221897 shows while recruiting

NCT00221897 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 235-participant average among 90 other Myopia trials with a reported enrollment target (1177% higher).

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 0 interventions.

NCT00221897 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00221897 about?

NCT00221897 is a clinical study titled "Diagnostic Innovations in Glaucoma Study". The overarching goal of our research study is to evaluate changes in visual function and optic nerve topography (the structure of the back of the eye) in patients with glaucoma (increased susceptibility to pressure inside the eye that can cause loss of vision) or those with an increased risk of deve...

What is the current status of trial NCT00221897?

This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 1995-04. Estimated completion is 2030-07.

What conditions does trial NCT00221897 study?

This clinical trial studies the following conditions: Myopia, Primary Open Angle Glaucoma.

Who is sponsoring clinical trial NCT00221897?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00221897 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00221897's enrollment target sits among peer trials

3,000 2nd of 90 the highest of 90 other Myopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

  • NCT00579566 · 3,000 participants

    Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • NCT00816114 · 3,000 participants

    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00221897, the US trial registry maintained by the National Library of Medicine. NCT00221897 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.